Risk score to stratify children with suspected serious bacterial infection: observational cohort study

Andrew J Brent1, Monica Lakhanpaul, Matthew Thompson

  • 1Working Group on Recognising Acute Illness in Children, Royal College of Paediatrics and Child Health, London, UK. dr.a.brent@gmail.com

Insights

A new clinical score can help identify children with serious bacterial infections (SBI) during acute illness. This tool aids in risk stratification for better clinical decision-making in pediatric emergency care.

Area of Science:

  • Pediatric Emergency Medicine
  • Infectious Diseases
  • Clinical Risk Stratification

Background:

  • Acute infections are common in children presenting to emergency departments.
  • Accurate risk stratification is crucial for timely management of serious bacterial infections (SBI).
  • Existing clinical signs have limitations in sensitivity for diagnosing SBI.

Purpose of the Study:

  • To derive and validate a clinical score for risk stratification of children with acute infections.
  • To identify clinical predictors of serious bacterial infection (SBI) in pediatric patients.

Main Methods:

  • Observational cohort study of 1951 children with suspected infections.
  • Prospective data collection on clinical features, investigations, and outcomes.
  • Multivariate logistic regression used to derive and validate a clinical risk score for SBI.

Main Results:

  • 74 (3.8%) children were diagnosed with SBI.
  • A derived clinical score demonstrated reasonable ability to discriminate SBI (AUC 0.77).
  • The score effectively risk-stratified children with suspected SBI.

Conclusions:

  • A derived clinical score shows potential utility in risk stratifying children with suspected SBI.
  • Further validation in diverse settings is recommended.
  • Integration into broader management algorithms could enhance clinical decision-making.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...